Control of Respiration

Breathing is automatic yet voluntarily over-ridable, driven by a brainstem rhythm generator that is continuously tuned by chemical (PCO2, PO2, pH) and mechanical (stretch) feedback. For NEET PG, the medullary and pontine centres, the dominance of the central chemoreceptor PCO2 drive, the hypoxic drive in COPD, and abnormal breathing patterns (Cheyne–Stokes, apneustic) are the perennial favourites.

Overview of the control system

Respiratory control is a classic negative-feedback loop with three components:

1. Sensors → chemoreceptors (central + peripheral) and mechanoreceptors (stretch, irritant, J-receptors).
2. Central controller → respiratory centres in the medulla and pons.
3. Effectors → respiratory muscles (diaphragm via phrenic nerve C3–C5, intercostals, accessory muscles).

Sensor (detect change) → afferent signal → central controller (integrate) → efferent (phrenic/intercostal nerves) → effector muscles → change in ventilation → corrects the disturbance.

High-yield: The single most important minute-to-minute regulator of ventilation at rest is arterial PCO2, acting chiefly through the central chemoreceptors in the medulla (via CSF H⁺).

The respiratory centres

The brainstem houses the rhythm generator and its modulators. There is no single "respiratory centre"; rather, anatomically and functionally distinct groups exist.

Medullary centres

• Dorsal respiratory group (DRG): Located in/around the nucleus tractus solitarius (NTS). Primarily inspiratory. Receives afferents from cranial nerves IX (glossopharyngeal) and X (vagus) — i.e., from peripheral chemoreceptors, baroreceptors, and lung stretch receptors. Drives the diaphragm via the phrenic nerve. Generates the basic ramp signal of inspiration.
• Ventral respiratory group (VRG): Contains both inspiratory and expiratory neurons. Largely quiescent during quiet breathing (passive expiration); becomes active during forceful breathing/exercise to drive expiratory muscles (abdominals, internal intercostals).
• Pre-Bötzinger complex: Part of the VRG; considered the primary rhythm generator (pacemaker) of inspiration. A frequently tested newer fact.

Pontine centres

• Pneumotaxic centre (Pontine respiratory group): In the upper pons (nucleus parabrachialis / Kölliker–Fuse). Switches off inspiration ("inspiratory off-switch"), thereby limiting tidal volume and secondarily increasing respiratory rate. Strong pneumotaxic signal → shorter inspiration → faster, shallower breathing.
• Apneustic centre: In the lower pons. Promotes/prolongs inspiration (excites the DRG). Normally inhibited by the pneumotaxic centre and vagal afferents.

Centre	Location	Main function	Effect of stimulation
DRG	Medulla (NTS)	Inspiration (ramp generator)	Inspiration
VRG	Medulla	Inspiration + active expiration	Forceful breathing
Pre-Bötzinger	Medulla (VRG)	Rhythm pacemaker	Sets basal rhythm
Pneumotaxic	Upper pons	Inspiratory off-switch	↓ Ti, ↑ rate, ↓ TV
Apneustic	Lower pons	Prolongs inspiration	Apneusis (sustained inspiratory gasps)

High-yield (lesion localisation): Transection above the pons → normal breathing. Below the medulla → breathing stops (apnoea). Loss of pneumotaxic centre + vagi cut → apneustic breathing (prolonged inspiratory holds). This is a classic "where is the lesion" MCQ.

Apneusis — the rule

Apneustic breathing appears only when BOTH the pneumotaxic centre is lost AND the vagi are sectioned. If the vagi are intact, lung-stretch (Hering–Breuer) afferents can still terminate inspiration, masking apneusis.

Chemical control — the heart of regulation

Central chemoreceptors

• Located on the ventral surface of the medulla, anatomically separate from the DRG/VRG.
• They sense H⁺ concentration of the CSF/brain interstitial fluid, NOT PCO2 or PO2 directly.
• CO2 diffuses freely across the blood–brain barrier; in CSF it forms H₂CO₃ → H⁺. Because CSF has little protein buffer, a rise in PCO2 produces a brisk fall in CSF pH → powerful stimulation.
• Account for ~70–80% of the ventilatory response to CO2.
• Do NOT respond to hypoxia. In fact, severe hypoxia depresses the central centres.

High-yield: Central chemoreceptors respond to H⁺ (from CO2), not directly to molecular CO2 or to O2. Charged H⁺ ions cannot cross the BBB, so a metabolic acidosis (e.g., DKA) stimulates ventilation mainly via the peripheral chemoreceptors initially.

CSF adaptation

With chronic hypercapnia, HCO₃⁻ is transported into the CSF over 1–2 days, normalising CSF pH and blunting the central CO2 drive. This explains the reduced CO2 sensitivity in chronic CO2 retainers (COPD).

Peripheral chemoreceptors

• Carotid bodies (at the bifurcation of the common carotid; afferent via CN IX – glossopharyngeal, Hering's nerve) and aortic bodies (arch of aorta; afferent via CN X – vagus).
• Highest blood flow per gram of any tissue in the body; contain glomus (type I) cells.
• Stimuli: ↓ PaO2 (the only sensor for hypoxia), ↑ PaCO2, ↓ pH.

Feature	Central chemoreceptors	Peripheral chemoreceptors
Site	Ventral medulla	Carotid & aortic bodies
Primary stimulus	CSF H⁺ (from CO2)	↓ PaO2 (also ↑CO2, ↑H⁺)
Respond to hypoxia?	No (depressed)	Yes
Respond to metabolic acidosis?	No (H⁺ can't cross BBB)	Yes
Speed	Slower	Fastest responder
Afferent nerve	—	CN IX (carotid), CN X (aortic)
Share of CO2 response	70–80%	20–30%

High-yield: The carotid body is the principal organ responding to arterial hypoxaemia and to metabolic acidosis. The aortic body has a greater role in cardiovascular (circulatory) responses. Removal of carotid bodies abolishes the hypoxic ventilatory drive.

The hypoxic ventilatory response threshold

Peripheral chemoreceptors fire substantially only when PaO2 falls below ~60 mmHg (the steep part of the curve). Above this, the ventilatory response to falling O2 is minimal — which is why the body tolerates moderate hypoxaemia poorly only below 60 mmHg.

CO2 response curve and the ventilatory drives

• The CO2–ventilation relationship is nearly linear and steep: a rise of ~1 mmHg PaCO2 raises minute ventilation by ~2–3 L/min. CO2 is by far the most potent normal respiratory stimulant.
• Hypoxia and acidosis shift the CO2 response curve to the left and make it steeper (more ventilation for any given CO2).
• During sleep, anaesthesia, and with opioids/sedatives, the curve shifts right and flattens (blunted CO2 sensitivity → hypoventilation).

Order of ventilatory drive potency (normal person): PaCO2 (via CSF H⁺) >> PaO2 (only when <60 mmHg) ≈ arterial pH.

Hypoxic drive in COPD — the exam classic

In chronic CO2 retainers (e.g., advanced COPD, "blue bloaters"):

1. Chronic hypercapnia → renal HCO₃⁻ retention and CSF HCO₃⁻ buffering → central chemoreceptors become desensitised to CO2.
2. Ventilation now depends increasingly on the hypoxic drive from peripheral (carotid) chemoreceptors.
3. Giving high-flow uncontrolled O2 can abolish the hypoxic stimulus → hypoventilation, worsening hypercapnia, CO2 narcosis, and apnoea.

High-yield: In a CO2-retaining COPD patient, give controlled (low-flow) oxygen, targeting SpO2 88–92% (PaO2 ~60 mmHg). The mechanism of CO2 rise with high O2 is now understood to be multifactorial — loss of hypoxic drive, worsened V/Q mismatch (release of hypoxic pulmonary vasoconstriction), and the Haldane effect — but for MCQs the loss of hypoxic drive is the classic answer, with V/Q being the more modern "best" answer when offered.

Reflex (mechanical) control

Hering–Breuer reflexes

• Inflation reflex: Lung distension stimulates slowly-adapting pulmonary stretch receptors (in airway smooth muscle) → afferents via the vagus → inhibits further inspiration (terminates inspiration, prolongs expiration). Protects against over-inflation.
• In adult humans it is weak at normal tidal volumes and operates only when TV exceeds ~1–1.5 L (e.g., exercise). It is more important in neonates.
• Deflation reflex: Lung collapse → increased inspiratory effort (basis of Head's paradoxical reflex / first breath of newborn).

High-yield: Hering–Breuer inflation reflex is vagally mediated; cutting the vagi abolishes it (and contributes to apneustic breathing when combined with pneumotaxic loss).

Other receptors

• Irritant (rapidly adapting) receptors — bronchospasm, cough, hyperpnoea (dust, smoke, cold air).
• J-receptors (juxtacapillary) — in alveolar walls near capillaries; stimulated by pulmonary congestion/oedema, embolism → rapid shallow breathing, dyspnoea; vagal afferents.
• Joint/muscle proprioceptors — drive the hyperpnoea at the onset of exercise.

Abnormal breathing patterns

Pattern	Description	Localisation / cause
Cheyne–Stokes	Crescendo–decrescendo with apnoeic pauses	CHF, ↑ circulation time, bilateral cerebral/diencephalic lesions, high altitude
Biot's (ataxic)	Irregular, chaotic clusters with apnoea	Medullary damage, ↑ ICP, meningitis
Kussmaul	Deep, rapid, sighing	Metabolic acidosis (DKA, uraemia)
Apneustic	Prolonged inspiratory holds	Lower pons (pneumotaxic loss + vagotomy)
Central neurogenic hyperventilation	Sustained rapid deep breathing	Midbrain/upper pons lesion

High-yield (Cheyne–Stokes mechanism): A feedback instability/loop-gain problem — delayed sensing of arterial CO2 (prolonged circulation time as in CHF) causes ventilation to overshoot and undershoot. Apnoea → CO2 rises → hyperpnoea → CO2 falls below apnoeic threshold → apnoea again. It is not simply "low CO2."

Sleep, exercise, and high altitude

• Sleep: CO2 sensitivity falls; NREM has regular breathing; REM is irregular. Loss of "wakefulness drive" can unmask central apnoeas.
• Exercise: Minute ventilation rises in proportion to CO2 production; remarkably, arterial PCO2, PO2 and pH stay near normal during moderate exercise. Drive comes from neural (cortical feedforward, joint/muscle afferents) and humoral factors rather than a measurable change in blood gases.
• High altitude: Hypoxia → peripheral chemoreceptor stimulation → hyperventilation → respiratory alkalosis → renal HCO₃⁻ excretion over days (acclimatisation) restores ventilatory drive. Acetazolamide (carbonic anhydrase inhibitor) induces a mild metabolic acidosis to drive ventilation and aids acclimatisation/prevents AMS.

Pharmacology & clinical correlates

• Opioids: Depress the medullary response to CO2 (right-shift, flatten curve) → most dangerous respiratory depressant; reversed by naloxone.
• Benzodiazepines, barbiturates, anaesthetics: Blunt CO2 response.
• Doxapram: Respiratory stimulant acting on peripheral chemoreceptors (low dose) and central centres.
• Ondine's curse (congenital central hypoventilation syndrome): Failure of automatic breathing (loss of central chemoreceptor drive) with preserved voluntary breathing — patient breathes when awake but hypoventilates during sleep. Associated with PHOX2B mutation.

Investigations / assessment

• Arterial blood gas (ABG): Cornerstone — defines hypercapnia (PaCO2 >45), hypoxaemia (PaO2 <80), and acid–base status.
• End-tidal CO2 (capnography): Continuous monitoring of ventilation.
• Polysomnography: For sleep-related breathing disorders (central vs obstructive apnoea).
• Ventilatory response tests: Hypercapnic and hypoxic ventilatory response curves quantify chemosensitivity.

Key differentials / distinctions to remember

• Central vs peripheral chemoreceptor roles (see table) — the most tested distinction.
• Central sleep apnoea (no respiratory effort, e.g., Cheyne–Stokes) vs obstructive sleep apnoea (effort present but airflow blocked).
• Type II respiratory failure (hypoventilation, ↑CO2) vs Type I (V/Q/diffusion, normal/low CO2).

Mnemonics

• "Dorsal Drives Diaphragm, Ventral for Vigorous (forceful) breathing."
• Pontine centres: "PneumoTaxic = Turns off / Terminates inspiration; APneustic = Adds / Augments inspiration."
• Carotid body afferent = glossopharyngeal (IX); aortic body = vagus (X) → "Carotid Calls IX, Aorta Asks X."

Recently asked / exam angle

• Lesion–pattern matching: "Transection between pons and medulla with vagi cut produces ___" → apneustic breathing. A perennial PGI/NEET item.
• Primary stimulus of central chemoreceptors → H⁺ in CSF (not CO2 directly, not O2). Distractors include "PCO2 of blood" and "PO2."
• COPD + high-flow O2 → CO2 narcosis: classic clinical vignette; answer hinges on loss of hypoxic drive ± V/Q worsening; target SpO2 88–92%.
• Carotid body as the chief hypoxia sensor and key metabolic acidosis sensor.
• Pre-Bötzinger complex = rhythm generator (newer, increasingly asked).
• Cheyne–Stokes linked to CHF / prolonged circulation time, and seen at high altitude during sleep.
• Acetazolamide mechanism in high-altitude acclimatisation (metabolic acidosis → ventilatory drive).
• Hering–Breuer inflation reflex is vagal and more significant in neonates.
• Ondine's curse / PHOX2B — failure of automatic but not voluntary respiration.

Rapid revision

1. Resting ventilation is governed chiefly by arterial PCO2 via central chemoreceptors sensing CSF H⁺.
2. Central chemoreceptors (ventral medulla) respond to H⁺/CO2, never to hypoxia; severe hypoxia depresses them.
3. Carotid bodies (CN IX) are the sole hypoxia sensors; respond when PaO2 <60 mmHg, and to metabolic acidosis.
4. DRG (NTS) = inspiration; VRG = forceful breathing; pre-Bötzinger = rhythm pacemaker.
5. Pneumotaxic centre switches off inspiration (↑rate, ↓TV); apneustic centre prolongs inspiration.
6. Apneustic breathing = pneumotaxic loss + vagotomy together.
7. CO2 response curve is steep and linear; opioids/anaesthetics flatten and right-shift it.
8. In CO2-retaining COPD, ventilation runs on hypoxic drive; give controlled O2, target SpO2 88–92%.
9. Hering–Breuer inflation reflex is vagal, weak in adults, important in neonates, protects against over-inflation.
10. Cheyne–Stokes = loop-gain instability with prolonged circulation time (CHF), apnoea–hyperpnoea cycling.
11. Kussmaul = deep rapid breathing of metabolic acidosis (DKA); Biot's/ataxic = medullary damage.
12. Acetazolamide aids altitude acclimatisation via metabolic acidosis; Ondine's curse = PHOX2B, loss of automatic breathing.